Navigation Links
Concentric Launches New Consumer Division, Names Mike Devlin EVP, Managing Director
Date:2/4/2008

NEW YORK, Feb. 4 /PRNewswire/ -- Deepening its commitment to empowering patients and connecting people and their healthcare providers, Concentric Pharma Advertising, a five-year-old independent agency and one of the fastest growing in the field, has established a new business unit geared to educating consumers. The new division will be headed by industry veteran Mike Devlin, who joins the agency as executive vice president and managing director.

"Clients today are demanding integrated thinking, which requires a deep understanding of the dynamic between providers, patients and payers," said Ken Begasse Jr., partner and chief operating officer at Concentric. "Strengthening our consumer capabilities and aligning them with our professional expertise enables us to better serve our clients and to take a leadership role in the delivery of truly integrated communications."

Noting that Concentric has worked in the consumer arena since its inception (consumer business currently accounts for approximately 25 percent of agency revenue), Begasse emphasized that the creation of the new consumer group represents an expanded commitment to consumer communications. "Formalizing our consumer division under Mike supports our corporate objective to not just play in this arena but to lead it," he said.

Devlin, who brings 20 years of diverse healthcare experience to his new post, is a long-time advocate of integrated consumer communications. "In healthcare, silos don't work. Today's patients are savvy and are yearning for meaningful information -- dialogue -- that empowers them to improve their health and the health of their families. Consumer communications must be more integrated because enabling people to navigate information is the path to better experiences and outcomes."

Devlin, formerly executive creative director and a founding member of CCA Advertising in New York, has worked in a broad range of therapeutic categories and directed successful cam
'/>"/>

SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
2. Movement Against Cancer, a Cancer Patient Advocacy Group in Russia, Launches an Effort to Inform Russian Authorities and the Public About Inadequate Access of Innovative and Effective Cancer Treatments for Cancer Patients in Russia
3. Lifetime Television Launches Third Annual Dont Skip a Beat Multi-Platform Heart Health Awareness Initiative
4. Pharma Product Commercialization: Standardized Team Processes Help Save Complex Drug Launches
5. Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured
6. Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
7. Bridges to Excellence Launches Medical Home Program
8. Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury
9. Texas Health Care Association Launches New Educate 08 Effort to Help Focus Needed Attention on Long Term Care Issues, Medicaid Funding Crisis
10. Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide
11. Onmark Launches Integrated Quality(TM) Program to Help Physicians Succeed With National Quality Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... N.C. April 17, 2014 Meaningful long-term ... advanced cancer of the abdomen when treated with ... according to a first-of-its-size analysis by physicians at ... Baptist has the largest reported, single-center experience with ... A. Levine, M.D., and analysis of 20 years, ...
(Date:4/17/2014)... India,s shocking rates of suicide are highest in areas ... tiny smallholdings less than one hectare and ... coffee, that are highly susceptible to global price fluctuations. ... studies that point to a crisis in key areas ... nation,s economy during the 90s. Researchers say that policy ...
(Date:4/17/2014)... Professor Patrick Johnston, whose work has transformed cancer care ... of the European Academy of Cancer Sciences., The Academy, ... body of highly distinguished oncologists and cancer researchers which ... cancer in Europe. , Professor Johnston, whose leadership has ... the bottom of the UK league table to near ...
(Date:4/16/2014)... Consider the marvel of the embryo. It begins as a ... they multiply to become the cells of our lungs, muscles, ... , Now, in a feat of reverse tissue engineering, Stanford ... that allows embryonic cells to proliferate and transform into all ...
(Date:4/16/2014)... A team that includes scientists from the School of ... San Antonio, Johns Hopkins University and St. Mary,s University reported ... to infect the body. , The fungal pathogen Candida ... and is the most common fungal pathogen to infect humans. ...
Breaking Medicine News(10 mins):Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... UNICEF is making a difference in Somalia despite difficult circumstances; ... Urges world to remember Somali ... today ended a five-day visit to the troubled east African,nation ... plight of that,country,s children., (Photo: http://www.newscom.com/cgi-bin/prnh/20080703/NYTH023 ), ...
... Organizations, SOUTH PORTLAND, Maine, July 3 ... $1.4 million to community organizations,throughout Maine in 2007. ... the recently released Maine Community Relations,Report - 2007. ... ., "All associates at Anthem Blue Cross ...
... available in Spanish . , ,Scientists of the ... have confirmed that stem cells from human umbilical cord blood ... diseases such as hepatitis, and therefore mean an effective alternative ... be shortly published in the renowned journal Cell ...
... Pa., July 3 Eileen Connelly,Executive Director of ... called on the Pennsylvania School,Employees, Retirement System (PSERS) ... steering clear of an investment management firm,affiliated with ... lost,money for PSERS annuitants and whose past is ...
... Juicy Juice will encourage Hispanics to ... exercise and eat ... the return of last year,s successful junior soccer,tournament, Copita Juicy Juice. ... summer, and include the participation of over 600,children and more than ...
... ON, Canada Titanium implants were successfully introduced ... the,rehabilitation of edentulous jaws. After 40 years of ... frequently used,biomaterial in oral implantology, and titanium-based materials ... several parts of the,body. , There are some ...
Cached Medicine News:Health News:UNICEF Ambassador Clay Aiken Visits North-West Somalia 2Health News:UNICEF Ambassador Clay Aiken Visits North-West Somalia 3Health News:Anthem Blue Cross and Blue Shield Issues Community Report for 2007 2Health News:Stem cells from umbilical cord used in the treatment of hepatic diseases 2Health News:Major Union Questions PA Pension Fund, Calls on PSERS to Protect Workers, Retirees 2Health News:Nestle Juicy Juice Kicks Off Summer Promoting Nutritious, Active Lifestyle Choices Among Latino Children, Families 2Health News:Nestle Juicy Juice Kicks Off Summer Promoting Nutritious, Active Lifestyle Choices Among Latino Children, Families 3
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... EPODURE Biopump demonstrates safety and efficacy for four months ... Review Board confirms safety and efficacy of low dose ... trial with higher doses-- Biopump may offer alternative to ... Medgenics (AIM: MEDU/MEDG), today announced that the EPODURE ...
... FRANCISCO, Calif., Feb. 3 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... will delay,further partnership discussions regarding R788 until after ... are available. The company expects that,these ... the understanding of R788,s potential and may therefore,drive ...
Cached Medicine Technology:Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 2Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 3Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 4Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease 5Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 2Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 3Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 4Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 5
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 ga. shaft tapering to 23 ga., 10 mm from tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. Ultra-fine 3.35 mm tips. Angled 55 degrees. 20 gauge shaft. 30 mm in length. Overall length from rear rotation knob to tip....
For use with the Landers Vitrectomy Lens set (MVS 1079A). Shafts angled 45 degrees with curved grooved blades for holding the Landers vitrectomy lenses. Polished finish....
Ergotec Vetriretinal Instrument System. 2 mm pointed tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Medicine Products: